Harrow Health, Inc. (HROW)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$29.07
—
Mkt Cap $1.09B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (15 analysts)
$66.50
Range $45.00 – $88.00
Implied Upside
+128.8%
Consensus $66.50 vs current $29.07